TrialPsychopharmacology2019

An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial.

Tomasz Pawełczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.